Install
- 190articles · 30d
- 16+ hour agolatest article
- Aug 15, 2026earliest in window
- 93%with images · 4 videos
- 225avg words
- Medical 168
- Health 166
- Health & Wellness 162
- Crime, Law & Justice 12
- News 9
- Sensitive Subjects 9
- Crime & Law 8
- Politics 8
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Cefepime Tied to Higher Mortality Odds vs Other Beta-Lactams
3+ day, 21+ hour ago (135+ words) The danger may be in the dosing, not in the drug itself...
IL-33 Inhibitor Delivers in COPD Trials
4+ day, 15+ hour ago (661+ words) — Tozorakimab highly promising as biologic therapy in replicate phase III trials A broad population of people with chronic obstructive pulmonary disease (COPD), current and former smokers alike, experienced fewer exacerbations taking a first-in-class biologic targeting interleukin (IL)-33, a pair of…...
H. Pylori Exposure and Colorectal Cancer: The Evidence Grows
4+ day, 15+ hour ago (614+ words) — Modeling study suggests an association Exposure to Helicobacter pylori, known for its role in gastric cancer, may also play a role in colorectal cancer (CRC), according to results from a risk-attribution modeling study. Based on estimates from 43 studies, H. pylori…...
Blood Cancer's First New Drug in 29 Years; AI for Mammography? Phase III Myeloma Win
1+ week, 3+ day ago (229+ words) — News, features, and commentary about cancer-related issues The FDA approved ropeginterferon alfa-2b (Besremi) injection to treat adults with essential thrombocythemia, the first new therapy for the chronic blood cancer since the 1997 approval of anagrelide. A national survey showed that almost…...
Is Paxlovid Any Better Than Placebo for Long COVID?
1+ week, 3+ day ago (181+ words) In three major symptom phenotypes, randomized trial finds no benefit...
Dramatic Improvement in Dermatomyositis Skin Symptoms With First Approved Oral Agent
1+ week, 3+ day ago (29+ words) Lesion clearance rate, itch reduction doubled with TYK2/JAK1 inhibitor brepocitinib...
Sad Trial Names: Social Media Thinks Cardiology Is Going Through It
1+ week, 4+ day ago (376+ words) — Two trials from the same research group sound like vulnerable relationship status updates Cardiology is going through it -- so say commenters on social media, at least. During last week's European Society of Cardiology (ESC) meeting in Munich, a trial name…...
FDA Adds Boxed Warning to Iron Replacement Injection
1+ week, 5+ day ago (167+ words) — Label change for ferric carboxymaltose warns of risk for symptomatic hypophosphatemia The FDA approved a label change for ferric carboxymaltose injection (Injectafer) that adds a boxed warning for the risk of symptomatic hypophosphatemia. The agency recommends monitoring of phosphate levels…...
GLP-1 Drugs Tied to Gallbladder and Biliary Risks in Youth
1+ week, 6+ day ago (427+ words) — Real-world study identifies safety signal in young people with overweight or obesity Use of GLP-1 receptor agonists was associated with increased cumulative gallbladder and biliary events in youths, according to a retrospective analysis of TriNetX data. Among over 37,000 adolescents and…...
First-in-Class Drug Wins FDA Approval for Polycythemia Vera
1+ week, 6+ day ago (320+ words) — Rusfertide mimics hepcidin to target erythrocytosis in rare blood malignancy The FDA approved first-in-class rusfertide (Mimrylo)opens in a new tab or window for treating erythrocytosis in adults with polycythemia vera (PV), a rare and slow-growing hematologic malignancy. Rusfertide mimics…...